GDR — Genedrive Share News
0.000.00%
Last trade - 00:00- £20.87m
- £20.99m
- £0.95m
Completion of placing
Brief: Genedrive PLC Announces Clinical Trial Agreement With Multi-State Physician Organisation in USA
Brief: Genedrive Says NICE Recommends Genedrive CYP2C19-ID Kit
Half-year Report
Investor presentation
NICE Early Value Assessment update
Director/PDMR Shareholding
Equity Prepayment Facility drawdown
Posting of annual report and notice of AGM
MT-RNR1 ID kit adopted for routine use in Brighton
Brief: Genedrive Says Will Need To Raise Further Funds In Early 2024
Final Results
Equity Prepayment Facility drawdown
Notice of Results
Brief: Genedrive Appoints James Cheek As CEO
Board changes
Brief: Genedrive Announces UKCA Marking Registration Achieved For Its New Genedrive® CYP2C19 System
Holding(s) in Company
UK's Genedrive jumps on receiving grant